Q linea AB
Q linea AB has a market price of 18.2 SEK and a market capitalization of 344,867,286.4 SEK. The company's price-to-book ratio is 5.06, and its price-to-tangible-book ratio is also 5.06. The enterprise value to EBITDA ratio is -5.83, indicating a negative EBITDA, and the enterprise value to revenue ratio is 2,396.18. The company's liquidity position is assessed as medium, with a current ratio of 1.19 and negative net cash after subtracting total debt. The company's profitability metrics are negative, with a return on equity of -0.9657 and a return on assets of -0.4137. The debt-to-equity ratio is 0.84, suggesting a moderate level of leverage. The operating cash flow is -92,088,000 SEK, and the free cash flow is -65,343,000 SEK, indicating significant cash outflows. Q linea AB's revenue is 159,000,000 SEK, and its gross profit is -27,300,000 SEK. The operating income is -65,374,000 SEK, and the net income is -65,774,000 SEK, showing substantial losses. The capital expenditure is -6,519,000 SEK, indicating ongoing investment in capital assets. The company's growth trajectory is uncertain, with a mean revenue estimate of 107,000,000 SEK and a mean EBIT estimate of -99,000,000 SEK. The last actual revenue was 11,098,000 SEK, and the last actual EPS was -27.40 SEK. The mean price target is 50.00 SEK, significantly higher than the current market price. The risk assessment indicates a medium liquidity risk and a low dilution risk. The key financial flag is the negative net cash after subtracting total debt, which could impact the company's ability to meet short-term obligations. Recent financial observations show that the company is experiencing significant financial challenges, with negative operating and net income, and a high price-to-revenue ratio. The company's financial health is a concern, and it may need to address its cash flow and profitability issues to sustain operations.
Business. Q linea AB is a healthcare equipment company that develops and sells advanced medical equipment and technology.
Classification. Q linea AB is classified in the Healthcare sector under the Advanced Medical Equipment & Technology industry with a confidence level of 0.92.
- Q linea AB is experiencing significant financial losses, with a net income of -65,774,000 SEK.
- The company's liquidity position is medium, with a current ratio of 1.19 and negative net cash after subtracting total debt.
- The enterprise value to revenue ratio is 2,396.18, indicating a high valuation relative to revenue.
- Analysts have set a mean price target of 50.00 SEK, which is significantly higher than the current market price of 18.2 SEK.
- The company's profitability metrics are negative, with a return on equity of -0.9657 and a return on assets of -0.4137.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.